Scientists test drug safety in people with liver issues
NCT ID NCT06734208
Summary
This study aimed to understand how a drug called divarasib is processed in people with different levels of liver problems compared to healthy people. It involved 31 participants, some with healthy livers and some with mild, moderate, or severe liver impairment. The main goal was to measure the drug's levels in the blood to see if liver problems change how the body handles it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Research Corporation Inc.
San Antonio, Texas, 78215, United States
-
Clinical Pharmacology of Miami, Inc.
Miami, Florida, 33014, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Panax Clinical Research, LLC
Miami Lakes, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.